NASDAQ INMB
Last Trade
Change
Change %
Days Range
52-Week Range
Volume
SIGN UP
Search
What’s New
About
Back
Corporate Overview
Management
Directors
Therapies
Back
Pipeline
INKmune™ – Cancer
Back
Overview
Clinical trials
Publications
Videos
INB03 – Cancer
Back
Overview
Presentations
Publications
Videos
XPro1595 – Alzheimer's
Back
Overview
Clinical trials
Publications
Videos
XPRO1595 – TRD
Back
Overview
Videos
Investors
Back
Corporate Governance
IR Events
Presentation
Filings
Stock Quote
Analyst Coverage
News and Media
Back
2023
2022
2021
2020
2019
2018
2017
Contact
Back
Contact Us
Subscribe for Updates
2023 News
Title Filter
All
Corporate
General
INmune Bio, Inc. Announces 2022 Results and Provides Business Update
02 Mar, 2023
INmune Bio, Inc. to Report Fourth Quarter and Full-Year 2022 Results and Provide a Corporate Update on Thursday, March 2
21 Feb, 2023
INmune Bio, Inc. Receives Approximately $6.4 Million in Research and Development Rebates from Australia and the United Kingdom
08 Feb, 2023
INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne Muscular Dystrophy
25 Jan, 2023
Have a Question?
858 964 3720
Email Us
dmoss@inmunebio.com
Opening Hours
M - F 8am to 5pm EST